Concepedia

Marius Žemaitis

MŽ

15

Publications

4K

Citations

12

H-Index

2006

Active since

Affiliations

Lithuanian University of Health Sciences(Current)

Eli Lilly (Germany)

Marius Žemaitis is an author at Lithuanian University of Health Sciences specializing in medicine, pathology, and lung cancer.

Top concepts

Publications per year

2006–2024

15

Publications

15

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer

Jurgita Jackutė, Marius Žemaitis, Darius Pranys et al. · BMC Immunology · 2018 · 253 citations · Full text

Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma

Jürgen R. Fischer, U. Ohnmacht, Norman Rieger et al. · Lung Cancer · 2006 · 94 citations

, , +9

Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease

Neringa Vagulienė, Marius Žemaitis, Simona Lavinskienė et al. · BMC Immunology · 2013 · 74 citations · Full text

Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine

Jürgen R. Fischer, U. Ohnmacht, Norman Rieger et al. · Lung Cancer · 2006 · 73 citations

, , +7

Rows per page

1–5 of 15